GSK has snagged FDA approval for its 5-in-1 meningococcal vaccine, propelling it to a familiar position: rivaling Pfizer.
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
Public Health said it investigated a case in a student last week at Cole Harbour High School. Close contacts were notified ...
Longtime anti-vaccine critic Robert F. Kennedy was confirmed Tuesday as the new Secretary of Health and Human Services.